ReviewJournal of clinical medicine2022

Comparison of Glucose-Lowering Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Shuyan Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.